See more : Dorel Industries Inc. (DIIBF) Income Statement Analysis – Financial Results
Complete financial analysis of Rennova Health, Inc. (RNVA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Rennova Health, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- PT RMK Energy Tbk (RMKE.JK) Income Statement Analysis – Financial Results
- Amplitude, Inc. (AMPL) Income Statement Analysis – Financial Results
- Everi Holdings Inc. (EVRI) Income Statement Analysis – Financial Results
- Luks Group (Vietnam Holdings) Company Limited (LKSGF) Income Statement Analysis – Financial Results
- Aether Catalyst Solutions, Inc. (ATHR.CN) Income Statement Analysis – Financial Results
Rennova Health, Inc. (RNVA)
About Rennova Health, Inc.
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. As of December 31, 2021, it owns one operating hospital in Oneida, Tennessee; an acute care hospital and a physician's practice in Jamestown, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company was founded in 2005 and is based in West Palm Beach, Florida.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.04M | 3.22M | 7.20M | 15.99M | 14.55M | 4.62M | 5.25M | 18.39M | 498.00K | 658.00K | 400.00K | 100.00K | 16.00K | 12.40M | 13.07M | 32.93M | 22.26M | 21.76M | 14.89M | 16.53M | 14.10M | 21.61M | 38.21M | 26.44M | 29.00M | 41.50M | 57.40M | 62.00M | 44.60M | 38.02M | 42.78M | 42.16M | 40.99M |
| Cost of Revenue | 6.77M | 5.29M | 11.78M | 14.85M | 11.51M | 948.84K | 1.70M | 9.34M | 72.00K | 158.00K | 56.00K | 0.00 | 0.00 | 15.74M | 7.87M | 18.91M | 16.74M | 15.74M | 11.62M | 11.88M | 14.17M | 14.93M | 22.93M | 15.65M | 19.00M | 22.10M | 29.20M | 32.10M | 23.00M | 21.51M | 23.32M | 18.37M | 24.31M |
| Gross Profit | 6.27M | -2.07M | -4.58M | 1.14M | 3.04M | 3.67M | 3.55M | 9.05M | 426.00K | 500.00K | 344.00K | 100.00K | 16.00K | -3.34M | 5.20M | 14.01M | 5.53M | 6.02M | 3.27M | 4.65M | -66.00K | 6.68M | 15.28M | 10.79M | 10.00M | 19.40M | 28.20M | 29.90M | 21.60M | 16.51M | 19.46M | 23.79M | 16.68M |
| Gross Profit Ratio | 48.08% | -64.16% | -63.66% | 7.14% | 20.89% | 79.46% | 67.68% | 49.22% | 85.54% | 75.99% | 86.00% | 100.00% | 100.00% | -26.97% | 39.77% | 42.56% | 24.83% | 27.65% | 21.94% | 28.12% | -0.47% | 30.90% | 39.99% | 40.81% | 34.48% | 46.75% | 49.13% | 48.23% | 48.43% | 43.42% | 45.49% | 56.43% | 40.69% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 415.48K | 2.17M | 284.00K | 457.00K | 0.00 | 0.00 | 7.70M | 5.21M | 3.71M | 4.65M | 4.75M | 5.77M | 5.51M | 4.82M | 5.93M | 8.94M | 10.06M | 9.60M | 11.00M | 10.50M | 10.00M | 0.00 | 7.35M | 7.49M | 9.73M | 10.40M |
| General & Administrative | 6.88M | 7.51M | 11.66M | 16.68M | 14.82M | 15.76M | 23.70M | 27.85M | 2.83M | 3.53M | 3.73M | 2.62M | 1.88M | 4.24M | 4.77M | 0.00 | 10.35M | 7.14M | 0.00 | 0.00 | 4.81M | 4.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.23M | 9.27M | 12.74M | 13.43M |
| Selling & Marketing | 323.51K | 0.00 | 0.00 | 0.00 | 4.55K | 742.64K | 2.46M | 3.76M | 293.00K | 271.00K | 249.00K | 0.00 | 0.00 | 2.44M | 3.16M | 0.00 | 3.91M | 2.96M | 0.00 | 0.00 | 2.92M | 4.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.21M | 7.51M | 11.66M | 16.68M | 14.83M | 16.50M | 26.15M | 31.61M | 3.12M | 3.80M | 3.98M | 2.62M | 1.88M | 6.69M | 7.93M | 8.71M | 14.26M | 10.10M | 9.36M | 6.32M | 7.74M | 8.98M | 12.20M | 12.10M | 14.00M | 12.70M | 12.20M | 12.00M | 19.20M | 10.23M | 9.27M | 12.74M | 13.43M |
| Other Expenses | 469.37K | 2.94M | 700.99K | 795.20K | 1.26M | 1.72M | 5.12M | 3.17M | 0.00 | 1.56M | 512.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 1.56M | 1.90M | 2.30M | 2.30M | 1.40M | 1.10M | 0.00 | -10.00K | 0.00 | 0.00 |
| Operating Expenses | 7.68M | 10.45M | 12.36M | 17.47M | 16.09M | 18.22M | 31.27M | 34.78M | 5.29M | 4.09M | 4.44M | 2.62M | 1.88M | 14.39M | 13.14M | 12.42M | 18.90M | 14.86M | 15.14M | 11.83M | 12.55M | 14.91M | 22.50M | 23.72M | 25.50M | 26.00M | 25.00M | 23.40M | 20.30M | 17.58M | 16.75M | 22.47M | 23.83M |
| Cost & Expenses | 14.45M | 15.74M | 24.15M | 32.32M | 27.60M | 19.16M | 32.97M | 44.11M | 5.37M | 4.25M | 4.50M | 2.62M | 1.88M | 30.13M | 21.01M | 31.33M | 35.64M | 30.60M | 26.76M | 23.71M | 26.72M | 29.84M | 45.43M | 39.37M | 44.50M | 48.10M | 54.20M | 55.50M | 43.30M | 39.09M | 40.07M | 40.84M | 48.14M |
| Interest Income | 0.00 | 3.19M | 9.84M | 21.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 291.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.26M | 3.19M | 9.84M | 21.73M | 21.53M | 21.43M | 6.32M | 2.69M | 0.00 | 0.00 | 0.00 | 2.03M | 0.00 | 740.00K | 0.00 | 0.00 | 481.00K | 1.44M | 2.06M | 5.52M | 8.00K | 495.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 700.00K | 800.00K | 0.00 | -1.21M | 1.16M | 1.34M |
| Depreciation & Amortization | 469.37K | 643.55K | 700.99K | 795.20K | 1.26M | 1.72M | 2.42M | 2.75M | 250.00K | 243.00K | 176.00K | 9.00K | 629.00K | 4.22M | 1.00M | 734.00K | 840.00K | 1.19M | 1.45M | 1.34M | 1.04M | 891.00K | 1.36M | 1.56M | 1.90M | 2.30M | 2.30M | 1.40M | 1.10M | 890.00K | 860.00K | -1.16M | -1.34M |
| EBITDA | -234.82K | -1.26M | -8.41M | -24.06M | -11.79M | -26.76M | -14.68M | -39.55M | -5.16M | -3.31M | -3.88M | -2.51M | -1.24M | -12.77M | -6.90M | 2.33M | -12.37M | -7.65M | -10.42M | -5.74M | -11.57M | -7.34M | -5.86M | -11.37M | -13.57M | -4.33M | 5.50M | 7.90M | 2.40M | -610.00K | 1.45M | 160.00K | -8.49M |
| EBITDA Ratio | -1.80% | -467.22% | -151.01% | -155.60% | -76.39% | -276.90% | -468.05% | -124.89% | -807.03% | -514.44% | -989.50% | -2,524.00% | -5,631.25% | -103.02% | -53.40% | -44.60% | -54.14% | -31.17% | -60.36% | -35.95% | -82.03% | -31.70% | -37.13% | -44.38% | -48.28% | -13.25% | 7.84% | 13.39% | 4.48% | -1.60% | 3.39% | 0.38% | -20.71% |
| Operating Income | -1.41M | -5.27M | -17.20M | -16.33M | -13.22M | -16.08M | -32.39M | -44.23M | -5.44M | -3.59M | -4.10M | -2.52M | -1.87M | -17.73M | -7.94M | 1.60M | -13.38M | -8.84M | -13.52M | -7.18M | -12.62M | -8.24M | -8.59M | -12.93M | -15.50M | -6.60M | 3.20M | 6.50M | 1.30M | -1.50M | 590.00K | 1.32M | -7.15M |
| Operating Income Ratio | -10.81% | -163.54% | -238.82% | -102.15% | -90.90% | -348.01% | -617.58% | -240.49% | -1,091.97% | -545.29% | -1,023.75% | -2,515.00% | -11,668.75% | -143.00% | -60.77% | 4.84% | -60.08% | -40.63% | -90.82% | -43.44% | -89.48% | -38.11% | -22.48% | -48.91% | -53.45% | -15.90% | 5.57% | 10.48% | 2.91% | -3.95% | 1.38% | 3.13% | -17.44% |
| Total Other Income/Expenses | -1.55M | 179.53K | -1.76M | -30.88M | 403.18K | -33.83M | -911.50K | 474.21K | -301.00K | 40.00K | -83.00K | -2.03M | 158.00K | -740.00K | 40.00K | 17.01M | 162.00K | -573.00K | -3.62M | -5.42M | -8.00K | -495.00K | 9.68M | 361.00K | 465.00K | 1.23M | 900.00K | -300.00K | -400.00K | 0.00 | 1.20M | -1.16M | -1.34M |
| Income Before Tax | -2.96M | -12.52M | -18.95M | -47.26M | -12.82M | -49.91M | -33.35M | -43.76M | -5.47M | -3.55M | -4.06M | -4.54M | -1.71M | -18.47M | -7.90M | 18.61M | -13.86M | -9.41M | -13.30M | -7.08M | -12.63M | -8.73M | 1.10M | -12.57M | -15.00M | -5.40M | 4.10M | 6.20M | 900.00K | -1.50M | 1.79M | 160.00K | -8.49M |
| Income Before Tax Ratio | -22.72% | -388.37% | -263.22% | -295.59% | -88.13% | -1,080.32% | -635.81% | -237.91% | -1,097.39% | -539.21% | -1,014.00% | -4,543.00% | -10,681.25% | -148.97% | -60.46% | 56.52% | -62.24% | -43.26% | -89.33% | -42.84% | -89.54% | -40.41% | 2.87% | -47.55% | -51.72% | -13.01% | 7.14% | 10.00% | 2.02% | -3.95% | 4.18% | 0.38% | -20.71% |
| Income Tax Expense | 312.85K | -179.53K | -1.31M | 13.17M | 766.07K | 1.02M | -735.03K | -9.03M | -301.00K | -79.00K | -83.00K | -1.10M | 1.60M | 1.48M | -80.00K | 504.00K | 319.00K | -532.00K | 2.86M | -198.00K | 16.00K | 990.00K | 25.00K | -722.00K | 100.00K | -2.30M | 1.00M | 600.00K | 100.00K | 0.00 | 270.00K | 230.00K | 150.00K |
| Net Income | -3.29M | -12.34M | -17.64M | -60.42M | -14.02M | -55.20M | -32.61M | -34.73M | -5.16M | -3.31M | -3.93M | -1.43M | -3.13M | -18.47M | -7.90M | 18.10M | -13.21M | -8.88M | -15.36M | -12.60M | -12.63M | -8.73M | 699.00K | -12.57M | -15.10M | -5.50M | 3.10M | 5.60M | 800.00K | -1.50M | 1.52M | -70.00K | -8.64M |
| Net Income Ratio | -25.26% | -382.80% | -245.05% | -377.96% | -96.38% | -1,194.90% | -621.79% | -188.82% | -1,036.95% | -503.65% | -982.00% | -1,429.00% | -19,562.50% | -148.97% | -60.46% | 54.99% | -59.35% | -40.81% | -103.19% | -76.25% | -89.54% | -40.41% | 1.83% | -47.55% | -52.07% | -13.25% | 5.40% | 9.03% | 1.79% | -3.95% | 3.55% | -0.17% | -21.08% |
| EPS | -0.03 | -22.50 | -59.06M | -1.08B | -1.17M | -18.40M | -452.13 | -1.26K | -2.22K | -7.45K | -9.07K | -3.81K | -8.35K | -49.25K | -21.18K | 3.80K | -41.81K | -28.55K | -78.78K | -93.35K | -213.98K | -167.88K | 23.28K | -273.28K | -387.18K | -141.03K | 81.58K | 151.35K | 266.67K | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.03 | -22.50 | -59.06M | -1.08B | -1.17M | -18.40M | -452.13 | -1.26K | -2.22K | -7.45K | -9.07K | -3.81K | -8.35K | -49.25K | -21.18K | 3.72K | -41.81K | -28.55K | -78.78K | -93.35K | -213.98K | -167.88K | 23.28K | -273.28K | -387.18K | -141.03K | 81.58K | 151.35K | 266.67K | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 9.99B | 548.38K | 0.30 | 0.06 | 12.00 | 3.00 | 72.13K | 27.61K | 2.33K | 445.00 | 433.00 | 375.00 | 375.00 | 375.00 | 373.00 | 321.00 | 316.00 | 311.00 | 195.00 | 135.00 | 59.00 | 52.00 | 46.00 | 46.00 | 39.00 | 39.00 | 38.00 | 37.00 | 3.00 | 28.89B | 28.89B | 28.89B | 28.89B |
| Weighted Avg Shares Out (Dil) | 9.99B | 548.38K | 0.30 | 0.06 | 12.00 | 3.00 | 72.13K | 27.61K | 2.33K | 445.00 | 433.00 | 375.00 | 375.00 | 375.00 | 373.00 | 321.00 | 316.00 | 311.00 | 195.00 | 135.00 | 59.00 | 52.00 | 46.00 | 46.00 | 39.00 | 39.00 | 38.00 | 37.00 | 3.00 | 28.89B | 28.89B | 28.89B | 28.89B |
RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
WEST PALM BEACH, Fla., March 26, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) announces that certain Series A, B and C warrants to purchase approximately 403,788,906,644 shares of common stock expired on March 21, 2024, and that on...
RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS
WEST PALM BEACH, Fla., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer, Seamus Lagan provides the following message to shareholders.
RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING
WEST PALM BEACH, Fla., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce a significant debt restructuring with its primary institutional investors. The restructuring extends the maturity date of approximately $8.2 million of secured...
RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS
WEST PALM BEACH, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) Chief Executive Officer Seamus Lagan recently joined Stock Day host Kevin Davis to provide an update after filing the 2023 second quarter financial statements and...
RENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS FIRST ALCOHOL AND DRUG TREATMENT FACILITY
WEST PALM BEACH, Fla., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA) is pleased to announce that its behavioral health services subsidiary, Myrtle Recovery Centers, Inc., (“Myrtle”), has been granted a license under the rules of the...
RENNOVA COMPLETES AGREEMENT TO SEPARATE ITS SOFTWARE AND GENETIC DIAGNOSTICS INTERPRETATION DIVISIONS INTO INNOVAQOR, INC. (OTC: INOQ) [UPDATED]
WEST PALM BEACH, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that on December 31. 2020, it completed an agreement...
RENNOVA HEALTH DISCUSSES BUSINESS UPDATE WITH THE STOCK DAY PODCAST
WEST PALM BEACH, Fla., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, announces that Rennova CEO and President of the Company, Seamus...
Rennova Health to Hold Business Update Conference Call on January 5
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Rennova Health, Inc. (NASDAQ:RNVA), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces the Company will host an investment community conference call on January 5, 2017 beginning at 4:30 p.m....
Rennova Health to Hold Second Quarter Financial Results Conference Call on August 15th
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update...
Rennova Health to Hold First Quarter Financial Results Conference Call on May 16th
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Rennova Health, Inc. (NASDAQ:RNVA) (NASDAQ:RNVAW), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, today announced that the Company will host a conference call and provide a business update on May...
Source: https://incomestatements.info
Category: Stock Reports